These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents. Rosenthal MD; Franson RC J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of eicosanoid formation in human polymorphonuclear leukocytes by high concentrations of magnesium ions. Ludwig P; Petrich K; Schewe T; Diezel W Biol Chem Hoppe Seyler; 1995 Dec; 376(12):739-44. PubMed ID: 9072050 [TBL] [Abstract][Full Text] [Related]
5. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2. Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363 [TBL] [Abstract][Full Text] [Related]
6. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC; Meier KE; Henderson WR J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073 [TBL] [Abstract][Full Text] [Related]
8. Modulation of human neutrophil LTA hydrolase activity by phorbol myristate acetate. McColl SR; Hurst NP; Betts WH; Cleland LG Biochem Biophys Res Commun; 1987 Sep; 147(2):622-6. PubMed ID: 2820409 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukotriene formation in human leukocytes by halothane. Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266 [TBL] [Abstract][Full Text] [Related]
10. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. Takata S; Matsubara M; Allen PG; Janmey PA; Serhan CN; Brady HR J Clin Invest; 1994 Feb; 93(2):499-508. PubMed ID: 7906693 [TBL] [Abstract][Full Text] [Related]
11. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Betts WH; Hurst NP; Murphy GA; Cleland LG Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444 [TBL] [Abstract][Full Text] [Related]
12. Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations. Antoine C; Murphy RC; Henson PM; Maclouf J Biochim Biophys Acta; 1992 Oct; 1128(2-3):139-46. PubMed ID: 1329972 [TBL] [Abstract][Full Text] [Related]
13. Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level. Chabannes B; Moliere P; Merhi-Soussi F; Poubelle PE; Lagarde M Br J Haematol; 2003 Apr; 121(2):341-8. PubMed ID: 12694258 [TBL] [Abstract][Full Text] [Related]
14. Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. Dahinden CA; Zingg J; Maly FE; de Weck AL J Exp Med; 1988 Apr; 167(4):1281-95. PubMed ID: 2833556 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of human neutrophil leukotriene synthesis by human granulocyte-macrophage colony-stimulating factor. McColl SR; Krump E; Naccache PH; Borgeat P Agents Actions; 1989 Jun; 27(3-4):465-8. PubMed ID: 2552774 [No Abstract] [Full Text] [Related]
16. The regulation of arachidonate lipoxygenase metabolite formation in cells derived from intrauterine tissues. Edwin SS; Thai D; LaMarche S; Branch DW; Mitchell MD Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):229-33. PubMed ID: 7784469 [TBL] [Abstract][Full Text] [Related]
17. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
18. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites. Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161 [TBL] [Abstract][Full Text] [Related]
19. Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils. Paubert-Braquet M; Mencia Huerta JM; Cousse H; Braquet P Prostaglandins Leukot Essent Fatty Acids; 1997 Sep; 57(3):299-304. PubMed ID: 9384520 [TBL] [Abstract][Full Text] [Related]
20. Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. McColl SR; Hurst NP; Cleland LG Biochem Biophys Res Commun; 1986 Dec; 141(2):399-404. PubMed ID: 3026382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]